Preliminary Evaluation of the New Hematology Analyzer COULTER® GEN•S™ in a University Hospital
-
Françoise Picard
Abstract
The COULTER® GEN·S™ system (COULTER® Corp, Miami, USA) is an automated hematology instrument that is designed to provide a complete hematological profile including white blood cells (WBC), complete blood count (CBC) differential count (diff) and the reticulocyte parameters. It was evaluated in our laboratory over a one month period. A preliminary study was performed using the GEN·S™ software revision 1D. The evaluation had two purposes: 1) evaluation of the GEN·S™ specifications; 2) comparison of its analytical performance with the hematology analyzer currently used in our laboratory.
The first part of the evaluation showed that the COULTER® GEN·S™ is reproducible, has linearity beyond the specifications given by the manufacturer and produces stable results up to 48 hours after blood collection.
The evaluation of analytical performance included: 1) a comparison between the GEN·S™ CBC and diff numerical results and the COULTER® STKS™ (COULTER® Corp, Miami, USA). These comparisons showed that the results given by the two methods are similar and suggested that the COULTER® GEN·S™ could replace the current hematology instrument in use in our laboratory; 2) a performance analysis, to measure the system's ability to detect morphologic abnormalities, when compared to the reference blood smear examination. This part of the evaluation was performed on both normal and abnormal samples. The results of this analysis showed that the sensitivity of the GEN·S™ was excellent, especially regarding blast cells, immature granulocytes, nucleated red blood cells (NRBCs) and platelet clumps when using the complete suspect flagging system of the instrument. In addition, the use of the review criteria in our laboratory allowed to detect all hematological diseases. The overall false negative rate was 0.9 %.
Thus we consider that the COULTER® GEN·S™ system is suited for use in medium-to large hospital laboratories which perform more than 100 CBC/day. Overall, the instrument had excellent performance, with a throughput of more than 100 samples/h. Its user friendly workstation has complete patient data management, which is in compliance with good laboratory practices in France.
Copyright © 1999 by Walter de Gruyter GmbH & Co. KG
Articles in the same Issue
- Meetings and Awards
- Are Cardiac Troponins the Myocardial Markers for the New Millenium?
- Leukocyte Activation Markers in Clinical Practice
- Hepatitis C Virus-Specific DNA Sequences in Human DNA: Differentiation by Means of Restriction Enzyme Analysis at the DNA Level of Healthy, Anti-HCV-Negative Individuals
- Characterization of Monoclonal Antibodies to Human Protein 1/Clara Cell 10 Kilodalton Protein
- Rapid Analysis of Parathion in Biological Samples Using Headspace Solid-Phase Micro-Extraction (HS-SPME) and Gas Chromatography/Mass Spectrometry (GC/MS)
- Semi-Automated Rapid Isoelectric Focusing of Apolipoproteins C from Human Plasma Using PhastSystem™ and Immunofixation
- The c-erbB-2 Oncogene Amplification by Competitive PCR in Aneuploid Cell Clones Flow Sorted from Breast Cancer Samples
- The Index of Individuality Is Often a Misinterpreted Quantity Characteristic
- Assessment of Package Inserts for Diagnostic Kits
- External Quality Assessment in Clinical Chemistry: Review of the Situation in Croatia with Particular Reference to Equipment
- Point-of-Care Testing: the Views of the Working Group of the Dutch Association of Clinical Chemistry
- Preliminary Evaluation of the New Hematology Analyzer COULTER® GEN•S™ in a University Hospital
- Use of Biochemical Markers in Acute Coronary Syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage
- Oxidative Stress in Skeletal Muscle. A.E. Rezuick, L. Packer, C.K. Sen. J.O. Hollosey and M.J. Jackson, editors
- Handbook of Lipoprotein Testing. N. Rifai, C.G. Warnick and M.H. Dominiczak, editors
- Erratum: Matthias Oberhoffer, Heinz Vogelsang, Stefan Rußwurm, Thomas Hartung and Konrad Reinhart. Outcome Prediction by Traditional and New Markers of Inflammation in Patients with Sepsis
Articles in the same Issue
- Meetings and Awards
- Are Cardiac Troponins the Myocardial Markers for the New Millenium?
- Leukocyte Activation Markers in Clinical Practice
- Hepatitis C Virus-Specific DNA Sequences in Human DNA: Differentiation by Means of Restriction Enzyme Analysis at the DNA Level of Healthy, Anti-HCV-Negative Individuals
- Characterization of Monoclonal Antibodies to Human Protein 1/Clara Cell 10 Kilodalton Protein
- Rapid Analysis of Parathion in Biological Samples Using Headspace Solid-Phase Micro-Extraction (HS-SPME) and Gas Chromatography/Mass Spectrometry (GC/MS)
- Semi-Automated Rapid Isoelectric Focusing of Apolipoproteins C from Human Plasma Using PhastSystem™ and Immunofixation
- The c-erbB-2 Oncogene Amplification by Competitive PCR in Aneuploid Cell Clones Flow Sorted from Breast Cancer Samples
- The Index of Individuality Is Often a Misinterpreted Quantity Characteristic
- Assessment of Package Inserts for Diagnostic Kits
- External Quality Assessment in Clinical Chemistry: Review of the Situation in Croatia with Particular Reference to Equipment
- Point-of-Care Testing: the Views of the Working Group of the Dutch Association of Clinical Chemistry
- Preliminary Evaluation of the New Hematology Analyzer COULTER® GEN•S™ in a University Hospital
- Use of Biochemical Markers in Acute Coronary Syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage
- Oxidative Stress in Skeletal Muscle. A.E. Rezuick, L. Packer, C.K. Sen. J.O. Hollosey and M.J. Jackson, editors
- Handbook of Lipoprotein Testing. N. Rifai, C.G. Warnick and M.H. Dominiczak, editors
- Erratum: Matthias Oberhoffer, Heinz Vogelsang, Stefan Rußwurm, Thomas Hartung and Konrad Reinhart. Outcome Prediction by Traditional and New Markers of Inflammation in Patients with Sepsis
